Wound Care News

By Industry News

Chicago, April 14, 2020 - The 6.5 million people living with chronic wounds in the US are also the most vulnerable to COVID-19: older adults and those with underlying health conditions. These patients require critical wound care that cannot be put on hold, yet to keep patients safe, many skilled nursing facilities are reducing access to visiting wound clinicians and many wound clinics are reducing hours or closing, leaving patients isolated from their much needed care providers. Improperly treated wounds can rapidly lead to infection, amputation, and death.

By Industry News

Toronto, CANADA and Baltimore, USA – April 16, 2020 – MolecuLight Inc., the leader in point-of-care fluorescence imaging for real-time detection of bacteria in wounds, announces the integration of its MolecuLight i:X® device with Tissue Analytics’ interconnected platform for seamless integration with leading EMR (electronic medical record) / EHR (electronic health record) platforms. Tissue Analytics is an AI-powered cloud-based software solution that allows providers to monitor and automatically measure wound healing.

By Industry News

Toronto, CANADA and Atlantic Beach, USA – April 1, 2020 – MolecuLight Inc., the leader in point-of-care fluorescence imaging for real-time detection of bacteria in wounds, announces its Sponsorship and participation in the Virtual Exhibit of its MolecuLight i:X® Platform at WoundCon™ Spring 2020. The virtual digital conference (www.woundcon.com) will be held on April 2, 2020 and has become the largest global conference for wound care, with over 11,500 wound care professionals registered for the
1-day clinical conference and virtual exhibition.

By Industry News

At the 2013 annual meeting of the Wound Healing Society, the first Thomas K. Hunt Endowed Lecture sponsored by the Wound Healing Foundation was presented as the Keynote Lecture. The lectureship was initiated to honor the legacy of Dr. Hunt and to inspire and educate wound healing researchers on related research innovations through the prestigious annual lecture.

By Shelley Ducker, Alliance of Wound Care Stakeholders

Coverage trends indicate that wound patients are increasingly being denied access to important products/services/procedures – or are being limited in receiving them – because of restrictions in payer coverage policies. Many times, restrictions – or utilization parameters – are out of step with clinical guidelines and current clinical practice.

By Industry News

Toronto, Canada – February 13, 2020 – MolecuLight Inc., maker of a handheld fluorescence imaging device for real-time detection of bacteria in wounds, announced that the American Medical Association (AMA) has issued two new CPT category lll codes to enable a reimbursement pathway for point-of-care real-time fluorescence wound imaging for bacterial presence, location and load using the MolecuLight i:X® procedure.

By Industry News

Toronto, Canada – February 10, 2020 – University Hospitals Ahuja Medical Center (UH) is the first clinical setting in Ohio using special technology to identify harmful bacteria, leading to healing for patients suffering from chronic wounds.

The Alliance of Wound Care Stakeholders is excited to kick-off 2020 by tackling a critical issue with impact across the wound care community: what and how much clinical evidence do payers need to cover wound care products and procedures? At their April Wound Care Evidence Summit in Washington D.C., the Alliance will convene payers, policymakers, and regulators to address this question and collaboratively build solutions to common challenges.

By Industry News

Edison, NJ (January 21, 2020) – MTF Biologics, a global nonprofit tissue bank, today announced a partnership with Net Health, the a provider of cloud-based software for specialized care. The collaboration allows MTF Biologics to offer its wound care solutions through Net Health’s WoundExpert® EMR for use in outpatient wound care centers throughout the United States.

By Industry News

January 16, 2020 – Smith+Nephew, the global medical technology business, today announces the publication of a new randomized controlled trial (RCT) which demonstrated that the use of PICO Single Use Negative Pressure Wound Therapy System (sNPWT) significantly reduced wound area, depth and volume compared to traditional negative pressure wound therapy (tNPWT) in patients with lower extremity ulcers.